tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
GH Research (GHRS)
NASDAQ:GHRS
US Market
GHRS
GH Research
RESEARCH TOOLSreports

GH Research (GHRS) Stock News & Sentiment

Compare
308 Followers
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting
Premium
Company Announcements
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting
5d ago
6K
GHRS
GH Research: Pivotal Pathway for GH001 in Treatment-Resistant Depression Supports $35 Target and Reiterated Buy Rating
Premium
Ratings
GH Research: Pivotal Pathway for GH001 in Treatment-Resistant Depression Supports $35 Target and Reiterated Buy Rating
8d ago
GHRS
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression
Premium
Company Announcements
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression
8d ago
6K
GHRS
GH Research: FDA Lifts Clinical Hold on GH001, Clearing Path to Phase 3 and Supporting Buy Rating
Premium
Ratings
GH Research: FDA Lifts Clinical Hold on GH001, Clearing Path to Phase 3 and Supporting Buy Rating
8d ago
GHRS
GH Research Sets January 5 Update on IND Status and Phase 3 Plans for Lead TRD Drug GH001
Premium
Company Announcements
GH Research Sets January 5 Update on IND Status and Phase 3 Plans for Lead TRD Drug GH001
11d ago
6K
GHRS
GH Research to Present Promising Results on GH001 at ACNP 2026
Premium
Company Announcements
GH Research to Present Promising Results on GH001 at ACNP 2026
2M ago
6K
GHRS
GH Research PLC Reports Q3 2025 Financial Results
Premium
Company Announcements
GH Research PLC Reports Q3 2025 Financial Results
2M ago
GHRS
More GHRS News >

GHRS News on the Web

Why GH Research PLC’s (GHRS) Stock Is Down 7.06%
AAII
Neutral
Why GH Research Is Rising In Pre-market?
rttnews
Neutral
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression
TipRanks News
Neutral
GH Research Awaits Key FDA Decision on GH001 as Phase 3 Depression Trial Advances
Market Chameleon
Neutral
FDA Greenlights GH001 for U.S. Trials—Phase 3 Launch Set for 2026 as Rapid-Acting Antidepressant Shows Promise
Market Chameleon
Neutral
After-Hours Gainers: GH Research, Phathom, Forte, OKYO, Zai Lab, LifeMD, Werewolf & Corvus Rally
rttnews
Neutral
Why GH Research PLC’s (GHRS) Stock Is Up 34.67%
AAII
Neutral
Why GH Research PLC’s (GHRS) Stock Is Up 5.35%
AAII
Neutral

News Score - Last 7 Days

Neutral
GHRS
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GHRS’s Media Buzz Sentiment?
1 articles about GHRS were published this week. In an average week, 2.75 articles are published.
    What is GHRS’s weekly average amount of articles?
    In an average week, 2.75 articles about GHRS are published.
      What is GHRS’s News Sentiment?
      59% of articles about GHRS were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        KRYSKrystal Biotech
        RVMDRevolution Medicines
        ANSLFAnsell
        RPRXRoyalty Pharma
        GLUEMonte Rosa Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week